Apollon Formularies (AQSE:APOL)' (AQSE:APOL) Stene Jacobs, COO, joins Proactive London to explain the announcement of a substantial increase in its production capacity in Negril, Jamaica.
He details how this will create further revenue generation opportunities with its state-of-the art distiller increasing production more than 50-fold compared with current levels.
The company has installed a specialist sonicator, which allows for the production of nano-particle medicines as well as water-oil emulsions. In addition, it has bought an industrial freeze drier, allowing it more flexibility to store freeze dried biomass for use on demand as well as for pharmaceutical applications.